Clinical Trials for Nova Pharmaceuticals

Explore 7 clinical trials worldwide

Showing 1-7 of 7 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Nova Pharmaceuticals

Clinical Trials (7)

NCT07071090
A Study of DC50292A Tablet in Patients With MTAP-deleted Advanced or Metastatic Solid Tumors
PHASE1Recruiting
32 participants
Started: Jun 30, 2025 · Completed: Jan 1, 2028
1 condition1 sponsor8 locations
NCT07038720
A Study of UA026 Tablets in Healthy Adult Subjects and Adult Subjects With Moderate to Severe Plaque Psoriasis
PHASE1Recruiting
124 participants
Started: May 8, 2025 · Completed: Jun 1, 2026
2 conditions1 sponsor1 location
NCT06757335
A Phase I/II Trial to Evaluate Oral HP568 Tablets in Patients with ER+/HER2 Advanced Breast Cancer
PHASE1/PHASE2Not yet recruiting
204 participants
Started: Jan 7, 2025 · Completed: Nov 27, 2026
1 condition1 sponsor0 locations
NCT06746519
BN104 in Combination With Chemotherapy or Targeted Agents for Acute Myeloid Leukemia
PHASE1/PHASE2Recruiting
135 participants
Started: Dec 25, 2024 · Completed: Jun 30, 2027
1 condition2 sponsors1 location
NCT06873555
A Study of DC05F01 in Chinese Patients with Recurrent/Refractory Ovarian Cancer and Other Advanced Solid Tumors
PHASE1/PHASE2Recruiting
60 participants
Started: Sep 11, 2024 · Completed: Aug 31, 2026
3 conditions1 sponsor2 locations
NCT06155084
A Phase I/II Study to Assess the Safety, Pharmacokinetics, and Anti-Tumor Activity of Oral HP518 in mCRPC Patients
PHASE1/PHASE2Recruiting
84 participants
Started: Dec 26, 2023 · Completed: Sep 30, 2026
1 condition1 sponsor27 locations
NCT03851640
A Trial Evaluating the Efficacy and Safety of HC-1119 Soft Capsules in Patients with Metastatic Castration-Resistant Prostate Cancer (mCRPC).
PHASE3Recruiting
417 participants
Started: Apr 12, 2019 · Completed: Sep 30, 2025
1 condition1 sponsor1 location